HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

NHLBI

LAM - Living With

Lymphangioleiomyomatosis  sirolimus  pneumothorax  lung disease in women 

With earlier diagnosis and newer treatment, patients with LAM are living longer, with some living more than 20 years after diagnosis. Your doctor will monitor your condition to see if it is stable or getting worse and causing serious complications. Also, your doctor may recommend other medical care, including vaccines, lifestyle changes, and pregnancy and birth control planning.

Preview   0 Users liked this content.
NHLBI

LAM - Treatment

Lymphangioleiomyomatosis  sirolimus  pneumothorax  lung disease in women 

While there is no cure for LAM, doctors treat LAM with sirolimus (rapamycin), a medicine that stabilizes lung function, treats an abnormal fluid buildup in the lung called chylothorax, and improves overall quality of life. They may also prescribe other medicines or therapies to control other symptoms or complications.

Preview   0 Users liked this content.
NHLBI

LAM - Diagnosis

Lymphangioleiomyomatosis  sirolimus  pneumothorax  lung disease in women 

LAM is diagnosed based on your medical history and the results from diagnostic lung function tests, imaging tests such as high-resolution CT scans, VEGF-D blood tests, or other procedures.

Preview   0 Users liked this content.
NHLBI

LAM - Signs, Symptoms, and Complications

Lymphangioleiomyomatosis  sirolimus  pneumothorax  lung disease in women 

The signs and symptoms of pneumonia can be mild or severe and may include lung cysts, increased VEGF-D levels, reduced lung function, reduced, oxygen levels in the blood, chest pain or aches, fatigue, frequent cough, shortness of breath, and wheezing. Possible complications may include tumors in the kidneys, blood in the urine, enlarged lymph nodes, pleural effusions, pneumothorax or collapsed lung, and swelling.

Preview   0 Users liked this content.
NHLBI

LAM - Risk Factors

Lymphangioleiomyomatosis  sirolimus  pneumothorax  lung disease in women 

LAM is a rare disease that mostly affects women of childbearing age.

Preview   0 Users liked this content.
NHLBI

LAM - Causes

Lymphangioleiomyomatosis  sirolimus  pneumothorax  lung disease in women 

Researchers do not know the exact cause of LAM or why it mainly affects women, but they believe genes and the female hormone estrogen play a role.

Preview   0 Users liked this content.
HHS - Office of Medicare Hearings and Appeals (OMHA)

Average Processing Time By Fiscal Year

Media/Journalists  General Public  Academics/Researchers  Health Care Professionals  Human Services Professionals  Public Policy Professionals/Advocates 

OMHA Average Processing Time By Fiscal Year for Level 3 of the Medicare Appeals Process.

Preview   0 Users liked this content.
CDC

Notes from the Field: Cardiac Dysrhythmias After LoperamideAbuse - New York, 2008-2016 | MMWR

state  statistics  educators  recommendations  CDC  statements  data  MMWR  quickstats  notifiable  diseases  accomplishments  united states  laboratorians  reports  articles  continuing education  Centers for Disease Control and Prevention  physicians  nurses 

The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).

Preview   0 Users liked this content.